Role of Ca2+-independent phospholipase A2 and store-operated pathway in urocortin-induced vasodilatation of rat coronary artery

Circulation Research

Volumn 101, Issue 11, 2007, Pages 1194-1203

  Smani, Tarik ^a   Domínguez Rodríguez, Alejandro ^a   Hmadcha, Abdelkrim ^b   Calderón Sánchez, Eva ^a   Horrillo Ledesma, Angélica ^b   Ordóñez, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

Author keywords

cAMP PKA; iPLA2; Store operated Ca2+ entry; Urocortin; Vasoconstriction

Indexed keywords

CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INOSITOL DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLINOSITOL; MESSENGER RNA; PHENYLEPHRINE; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DOWN REGULATION; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CALCIUM; CORONARY VESSELS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; RATS; SIGNAL TRANSDUCTION; UROCORTINS; VASODILATION;

EID: 36348949676     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.159053     Document Type: Article

References (44)

1. Jackson WF. Ion channels and vascular tone. Hypertension. 2000;35:173-178.
2. Freichel M, Schweig U, Stauffenberger S, Freise D, Schorb W, Flockerzi V. Store operated cation channels in the heart and cells of the cardiovascular system. Cell Physiol Biochem. 1999;9:270-283.
3. 2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci. 1998;19:266-269.
4. 3-receptor-mediated contraction of porcine coronary smooth muscle. Cell Calcium. 2005;38:457-467.
5. 2+ influx. Circ Res. 1999;84:210-219.
6. 2+ entry. J Biol Chem. 2003;278:11909- 11915.
7. 2+ pathway. Nat Cell Biol. 2004;6:113-120.
8. 2beta-mediated pathway. J Biol Chem. 2006;281:34926-34935.
9. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394-1397.
10. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 1995;378:287-292.
11. Scarabelli T, Knight R. Urocortins: take them to heart. Curr Med Chem Cardiovasc Hematol Agents. 2004;2:335-342.
12. Parkes DG, May CN. Urocortin: A novel player in cardiac control. News Physiol Sci. 2000;15:264-268.
13. 2 gene expression. FASEB J. 2003;17:2313-2315.
14. Lawrence KM, Townsend PA, Davidson SM, Carroll CJ, Eaton S, Hubank M, Knight RA, Stephanou A, Latchman DS. The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage. Biochem Biophys Res Commun. 2004;321:479-486.
15. + channels. Br J Pharmacol. 2002;135:1467-1476.
16. + channels in endothelium-independent relaxation by urocortin in the rat coronary artery. Cardiovasc Res. 2003;57:824-833.
17. Chen ZW, Huang Y, Yang Q, Li X, Wei W, He GW. Urocortin-induced relaxation in the human internal mammary artery. Cardiovasc Res. 2005;65:913-920.
18. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin- releasing factor in the rat isolated basilar artery. Br J Pharmacol. 1998;125:1164-1171.
19. 2+ sensitivity of contraction in mouse tail arteries is attributable to cAMP-dependent dephosphorylation of MYPT1 and activation of myosin light chain phosphatase. Circ Res. 2006;98:1159-1167.
20. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 2002;23:71-77.
21. Liu M, Large WA, Albert AP. Stimulation of beta-adrenoceptors inhibits store-operated channel currents via a cAMP-dependent protein kinase mechanism in rabbit portal vein myocytes. J Physiol. 2005;562:395-406.
22. 2+ influx in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2006;290:278-283.
23. 2+ release and ATP-dependent facilitation of arterial myocyte contraction. Proc Natl Acad Sci U S A. 2006;103:4316-4321.
24. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev. 2005;85:757-810.
25. 2+ release. FASEB J. 2002;16:1145-1150.
26. 2+ influx. Mol Pharmacol. 2004;66:702-707.
27. 2+ entry in vascular smooth muscle cells. J Pharmacol Exp Ther. 2006;317:488-499.
28. 2: structure and function. Biochim. Biophys. Acta. 2000;1488:28-39.
29. Balsinde J, Dennis EA. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages, J Biol Chem. 1996;271:31937-31941.
30. Morales S, Camello PJ, Alcón S, Salido GM, Mawe G, Pozo MJ. Coactivation of capacitative calcium entry and L-type calcium channels in guinea pig gallbladder. Am J Physiol. 2004;286:1090-1000.
31. 2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochemical J. 1994;300:665-672.
32. Kass GE, Llopis J, Chow SC, Duddy SK, Orrenius S. Receptor-operated calcium influx in rat hepatocytes. Identification and characterization using manganese. J Biol Chem. 1990;265:17486-17492.
33. Singaravelu K, Lohr C, Deitmer JW. Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. J Neurosci. 2006;26:9579-9592.
34. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182.
35. Zhou Y, Mitra S, Varadharaj S, Parinandi N, Zweier JL, Flavahan NA. Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. Circ Res. 2006;98:1439-1445.
36. 2-dependent gating of TRPM8 by lysophospholipids. J Biol Chem. 2006;281:40174-40182.
37. Murray KJ. Cyclic AMP and mechanisms of vasodilation. Pharmac Ther. 1990;47:329-345.
38. 2+ sensitisation of constriction of pressurised rat resistance arteries. Br J Pharmacol. 2004;141:678-688.
39. Terui K, Higashiyama A, Horiba N, Furukawa KI, Motomura S, Suda T. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol. 2001;169:177-183.
40. 2+ currents in aortic smooth muscle cells. Eur J Pharmacol. 1995;294:625-635.
41. Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, Shah S, Dedman AM, Flemming PK, McHugh D, Naylor J, Cheong A, Bateson AN, Munsch CM, Porter KE, Beech DJ. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res. 2006;98:1381-1389.
42. 2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. Am J Physiol Cell Physiol. 2005;288:475-482.
43. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem. 1997;272:29317-29321.
44. 2 induces a p53-dependent cell-cycle arrest in G1 phase. J Cell Sci. 2006;119:1005-1015.